Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01225354 · ClinicalTrials.gov registry record · Phase 4
Injectable Filler for Cheek Flattening
A Phase 4 study, sponsored by DeNova Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT01225354 is a Phase 4 study that has completed, run by DeNova Research. The registered enrollment target is 20 participants.
The verdict
NCT01225354, a Phase 4 study, has completed, sponsored by DeNova Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if Radiesse injections to the cheeks result in an altered and improved first impression and self esteem.
Interventions
- DRUG Calcium hydroxylapatite
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01225354
The ClinicalTrials.gov registry entry for NCT01225354 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DeNova Research, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Calcium hydroxylapatite is the first listed.
NCT01225354 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01225354 about?
NCT01225354 is a clinical study titled "Injectable Filler for Cheek Flattening". The purpose of this study is to determine if Radiesse injections to the cheeks result in an altered and improved first impression and self esteem.
What is the current status of trial NCT01225354?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2010-08. Estimated completion is 2011-10.
What interventions are being tested in trial NCT01225354?
The interventions under investigation include: Calcium hydroxylapatite (DRUG).
Who is sponsoring clinical trial NCT01225354?
This trial is sponsored by DeNova Research, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.